ABG Launches Clinical Strength Hearing Pill®

American BioHealth Group (ABG) announced today the introduction of clinical strength version of the popular selling The Hearing Pill®

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend

The Hearing Pill

Salt Lake City, UT (PRWEB) December 04, 2012

“Since 2004 “The Hearing Pill® has been a trusted supplement that effectively promotes hearing health”, comments Bryce Karlman of American BioHealth Group. The mounting evidence authored by leading research institutions, universities and the US military support the active ingredient in The Hearing Pill’s® ability to promote hearing health. The published papers have allowed ABG to share the encouraging results from peer reviewed clinical trials with the public. The results of these studies add to the extensive body of positive evidence done in the laboratory. The completed studies are published on TheHearingPill.com.”

The active ingredient is the first, orally available, product protected by a US patent that specifically addresses hearing health. American BioHealth Group holds the exclusive license issued by the Department of Defense- US NAVY to commercialize TheHearingPill.com. ABG has also secured funding from the California University System, US Navy and is a winner of the “World’s Best Technology Showcase.”

Karlman continues, “As we release the clinical strength version of The Hearing Pill® millions of individuals are reminded that they now have a safe and effective product that helps promote hearing health. This product is available now at http://www.thehearingpill.com without a doctors’ prescription. Further, based on the positive results as evidenced in clinical trials, we are accelerating our other product development plans and adding new compounds into our growing product pipeline. We will continue to work closely with a number of our valuable partners, domestically and internationally, with the objective of advancing development of other drugs and indications that treat hearing disorders. We are delighted to advance this important science to a level where now millions of individuals have access to this important development.”


Follow us on: Contact's Facebook